The use of biologic agents in the treatment of ocular manifestations of Behcet's disease.

The use of biologic agents in the treatment of ocular manifestations of Behcet's disease.

Item
http://www.wikidata.org/entity/Q34220221
Anti-TNF-alpha therapy and systemic vasculitis.Combination therapy of infliximab and thalidomide for refractory entero-Behcet's disease: a case report.Development of Immunopathogenesis Strategies to Treat Behçet's Disease.The future of uveitis treatmentCurrent and future treatments for Behçet's uveitis: road to remission.Improved clinical control of a challenging case of Behçet's disease with rituximab therapy.A comprehensive review and update on the biologic treatment of adult noninfectious uveitis: part II.Progress in the understanding and utilization of biologic response modifiers in the treatment of uveitis.SNPs in the TNF-α gene promoter associated with Behcet's disease in Moroccan patients.New approaches in immunotherapy of behçet disease.Behcet's disease with major vascular involvement.Surveying uveitis specialists-a call for consensus.Admission rate and characteristics of hospitalized systemic connective tissue disorders: analysis from a nationwide Thailand healthcare database.Long-Term Efficacy of Pegylated Interferon Alpha-2b in Behçet's Uveitis: A Small Case Series.Anti-TNF- therapy in patients with refractory uveitis due to Behcet's disease: a 1-year follow-up study of 124 patients
P2860

The use of biologic agents in the treatment of ocular manifestations of Behcet's disease.

Item
http://www.wikidata.org/entity/Q34220221
description
2011 nî lūn-bûn
@nan
2011 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
The use of biologic agents in the treatment of ocular manifestations of Behcet's disease.
@ast
The use of biologic agents in the treatment of ocular manifestations of Behcet's disease.
@en
The use of biologic agents in the treatment of ocular manifestations of Behcet's disease.
@nl
type
label
The use of biologic agents in the treatment of ocular manifestations of Behcet's disease.
@ast
The use of biologic agents in the treatment of ocular manifestations of Behcet's disease.
@en
The use of biologic agents in the treatment of ocular manifestations of Behcet's disease.
@nl
prefLabel
The use of biologic agents in the treatment of ocular manifestations of Behcet's disease.
@ast
The use of biologic agents in the treatment of ocular manifestations of Behcet's disease.
@en
The use of biologic agents in the treatment of ocular manifestations of Behcet's disease.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P698
P921
P356
P1433
P1476
The use of biologic agents in the treatment of ocular manifestations of Behcet's disease.
@en
P2093
P2860
P304
P31
P356
10.3109/08820538.2011.588665
P407
P433
P478
P50
P577
P698
P921